logo
Plus   Neg
Share
Email

Patterson Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

Providing an update on the impact of COVID-19, Patterson Cos., Inc. (PDCO) announced Monday that it is withdrawing its financial guidance for the full year 2020, which was initiated on February 27, 2020, given the disruption of North American and international market conditions and the inability to accurately predict the economic effects of COVID-19 and related government actions.

Entering the last month of the company's fiscal year, the company said COVID-19 and measures taken by various authorities in response to the pandemic have directly and indirectly impacted demand for dental and companion animal products and services.

The company said it is maintaining the continuity of its business operations and taken precautionary measures to protect the health and safety of our employees.

The measures include facilitating work from home, restricting travel and implementing a number of other recommended best practices in our headquarters, branch offices and fulfillment centers.

Patterson also took swift action to adjust or postpone non-essential projects to ensure the organization remains focused on meeting the needs of its customers.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL.
Follow RTT